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Introduction
The obese patient is at great risk of problems with endotracheal intubation and 
developing peri-operative respiratory and cardiovascular complications. The 
difficulties in moving and positioning the patient and gaining venous access 
add to the problems. Anaesthesia and surgery on an obese patient should not be 
undertaken lightly without a full understanding of the potential problems. This 
case report addresses these important key issues.
Case Report
Anaesthesia in the morbidly obese patient presents many challenges. The concern 
is airway management and in particular difficulties with intubation.[1]
We describe an obese female patient whose weight was 165 kg, height was 163.5 
cm and hence Body Mass Index (BMI) was 61.7. (BMI = body weight (in kg)/
height2 (in meters)).  She required a ventral hernia repair. 
Pre-operative anaesthetic evaluation used the Mallampati classification: 
• Class I: Soft palate, uvula, fauces, pillars visible.
• Class II: Soft palate, major part of uvula, fauces visible.
• Class III: Soft palate, base of uvula visible.
• Class IV: Only hard palate visible.
 Our patient fell into Class III with an almost absent neck with a limited range of 
movement of the head and neck. The thyromental distance (TMD) was greater 
than 6 finger breadths. The thyromental distance is measured from the thyroid 
notch to the tip of the jaw with the head extended.  Anything less than 7.0 cm 
warns the anaesthetist about possible difficulties with intubation. Our patient 
had a TMD of greater than 12 cm. All laboratory variables and vital signs were 
within normal ranges (pulse rate 71 bpm and a BP 100/60 mmHg).
The patient was positioned supine and all monitors were attached, pulse oximetry, 
non-invasive blood pressure (NIBP) and electrocardiogram (ECG). The patient 
was pre-oxygenated with 100% O2 via facemask. She was then pre-medicated 
with metoclopramide 10 mg IV and anaesthetized with propofol 200 mg IV and 
suxamethonium 100 mg IV. The first intubation attempt was unsuccessful with 
poor visualization of the vocal cords using the smaller laryngoscope (Macintosh 
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The purpose of this case report is to describe our experience of the anaesthetic 
management of a patient with morbid obesity undergoing general surgery. 
The obese patient is at great risk of problems with endotracheal intubation and 
developing peri-operative respiratory and cardiovascular complications. The 
difficulties in moving and positioning the patient and gaining venous access 
add to the problems. Anaesthesia and surgery on an obese patient should not 
be undertaken lightly without a full understanding of the potential problems. 
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size 4).  Intubation was successful using a Macintosh size 
5 laryngoscope and a 7mm endotracheal tube A size 3 
oropharyngeal airway was also inserted. The patient was 
ventilated mechanically using a volume control mode 
with a tidal volume of 1,000 mls at a rate of 6mls – 
8mls/minute. Sevoflurane 0-3.5 % was given. The peak 
inspiratory pressure was 35 cmH
2
O and the Inspiratory 
Expiratory (I:E) ratio of 1:2. A non-depolarizing muscle 
relaxant (atracurium 50 mg in total) was used during 
mechanical ventilation.
The patient remained haemodynamically stable during 
surgery and the emergence from anaesthesia was 
uneventful. She was ultimately extubated post-surgery 
and transferred to Post-Anaesthesia Care Unit (PACU). 
The whole anaesthesia course was uneventful.
Discussion
We are not aware of any reports of morbidly obese 
patients being anaesthetized for surgery at Princes Marina 
Hospital. The anaesthetic management of an obese 
patient is challenging. A number of factors need to be 
considered. An operating room with sufficient space is 
required. Positioning of the patient before induction of 
anaesthesia is important.  Ideally lifting equipment should 
be available: we did not have this facility.  Two operating 
tables should be placed side by side to accommodate the 
patient [2] but we had only one available. 
All necessary anaesthetic equipment must be immediately 
available in anticipation of difficulties.  An obese patient has 
high intra-abdominal pressure and decreased functional 
residual capacity (FRC), end-expiratory lung volume, and 
total lung capacity (TLC) making mechanical ventilation 
difficult. Muscle paralysis with muscle relaxants, further 
reduces lung volumes.
Pharmacokinetics & pharmacodynamics
Obesity affects drug pharmacokinetic and 
pharmacodynamic profiles. Most of the data on drug 
dosing are for non-obese patients.[3] The increase in 
extracellular volume, the larger fat mass and lean body 
weight all affect drug pharmacokinetics. The volume of 
distribution of lipophilic drugs is greater than in normal-
weight patients, whereas the hydrophilic drugs do not 
vary as much. The advice on the use of ideal body weight 
(IBW) or total body weight to calculate drug dosages is 
not always clear. For example, paralytics are dosed based 
on IBW and most analgesics are based on lean body 
weight. Due to the large doses required with the increased 
distribution volume and the risk of prolonged effects after 
discontinuation, lipophilic drugs such as barbiturates, 
benzodiazepines, and volatile inhalation agents, should 
be used with caution or minimally in obese patients. 
Anaesthesia can be easily maintained by either intravenous 
anaesthesia (IV) or inhalation anaesthesia.
The ideal inhalational anaesthetic has a short onset 
and short, reliable recovery profile. Desflurane is the 
inhalational agent of choice in obese patients, but 
sevoflurane can also be used as in our case.
Pulmonary System
Obese patients are at increased risk of having difficult 
to handle airways, as bag mask valve ventilation and 
intubation can be challenging. While increased BMI 
does not predict difficulty with laryngoscopy or tracheal 
intubation, greater neck circumference (>40 cm) and 
higher Mallampati score (>3) are better predictors of 
difficult intubation.
Although most patients in a supine position may 
successfully undergo tracheal intubation, other adjuncts, 
such as flexible fibreoptic wake-up intubation, video –
assisted laryngoscopy and laryngeal mask airway (LMA), 
should be readily available.
As the FRC in obese patients is diminished, lengthy 
periods of apnoea are not tolerated and patients easily 
deoxygenate.[4] It is therefore recommended that 
preoxygenation be used for denitrogenation using 100% 
fraction of inspired oxygen (FiO
2
).
For the pre-intubation process, it is often suggested 
that continuous positive airway pressure (CPAP) at 10 
cmH
2
O is used to reduce the development of atelectasis 
[4]. A typical intubation position for obese patients, using 
shoulder towels, is the reverse Trendelenburg or head-up 
position 25 to 40 degrees.
With the rise in BMI, obese patients with decreased FRC, 
and expiratory reserve capacity show a restrictive trend 
during anaesthesia.
Figure 1. Obese patient with very short neck 
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Lung volume, and compliance also decrease. For obese 
patients an increase in oxygen intake, respiratory 
resistance, and breathing function is observed.
These changes result in gas trapping and hence mismatching 
of the ventilation-perfusion ratio, hypoxaemia, and 
atelectasis which becomes worse with anaesthesia and 
paralysis. Furthermore, there is a higher incidence of 
obstructive sleep apnoea (OSA). The most common 
bariatric surgery procedures are gastric bypass, sleeve 
gastrectomy, adjustable gastric band and biliopancreatic 
diversion with duodenal switch.
The American Association of Clinical Endocrinologists 
(AACE), the Obesity Society (TOS) and the American 
Society for Metabolic and Bariatric Surgery (ASMBS) 
support polysomnographic preoperative screening and 
preoperative CPAP in patients at risk.
It has been shown that pre-operative CPAP decreases severe 
hypoxaemia, pulmonary vasoconstriction, postoperative 
complications and hospital length of stay. Postoperative 
CPAP decreases the risk of restrictive pulmonary disease 
and acute respiratory distress syndrome.[5]
The use of post-operative CPAP is recommended when 
pulse oximetry falls to 90% while sleeping and IV 
medications are no longer required for pain relief. There 
are no specific guidelines on ventilator techniques for 
obese patients. However, in the anaesthesiology literature 
recommendations indicate the use of at least 10 cmH
2
O 
of post-end expiratory pressure (PEEP) after induction.[5]
The use of high tidal volumes, PEEP and critical capacity 
manoeuvres to improve ventilation and oxygenation 
were recorded, although[5] showed little gain in high 
tidal volumes in an attempt to sustain FRCs. Extubation 
should be done after the defensive airway reflexes have 
been assessed and the recovery of muscle strength has been 
assessed, the patient is fully awake and able to execute 
commands and in the reverse Trendelenburg position. 
Once extubated, continuous pulse oximetry is used to 
detect subclinical periods of desaturation.
Following major surgery, supplemental oxygen should be 
given, with some physicians suggesting treatment times of 
at least 24 to 48 hours. Nasal CPAP was also prescribed 
postoperatively, in addition to supplemental oxygen.
Cardiovascular System
Obesity is a significant coronary heart disease risk factor. 
Obese patients must undergo a thorough cardiovascular 
examination prior to elective surgery. They are at a 
higher risk for hypertension and hence left ventricular 
hypertrophy, pulmonary hypertension, and coronary 
arterial occlusion.[6]
Investigations should include chest X-ray, 12-lead 
electrocardiography and polysomnography in patients 
with OSA. Echocardiography, spirometry, are needed in 
the presence of additional risk factors (e.g. heart diseases 
and COPD), and arterial blood gases. 
Perioperative beta-blockers like labetalol are recommended 
in healthy or suspected coronary artery disease patients. 
According to Leonard, Davies and Waibel[6] “Several 
side effects of beta-blockade, however, such as impaired 
tolerance to glucose, decreased insulin resistance and 
other metabolic anomalies, can be dangerous in highly 
obese patients or patients with metabolic syndrome. 
Other medicinal products including antihypertensives 
can be continued preoperatively. Routine intraoperative 
haemodynamic surveillance should be started using 
telemetry and controlling blood pressure.” 
Blood pressure arm cuffs should be long enough to encircle 
at least 75% of the arm and 40% of the width of  the arm. 
Conclusion
Obesity is increasing in Botswana especially among female 
patients. This poses a high risk to patients undergoing 
anaesthesia and surgery.  This is a concern for the whole 
team (anaesthetists, surgeons and nurses) which should 
be aware of the potential risks associated with morbidly 
obese patients. This case report exemplifies the difficulties 
in management. 
Disclosure: We did not receive funding from any source 
and there are no conflicts of interest
Role of authors: Senior anaesthesiologist: principal 
investigator and main author; Medical Officer – 
Anaesthesia Department: assisted in editing and provided 
clinical data on the anaesthetic management; other 
authors: assisted in editing.
References
1. Myatt J, Haire K. Airway management in obese 
patients. Current Anaesthesia & Critical Care 
2010;21(1):9-15. 
2. Fisher A, Waterhouse TD, Adams A P. (1975). 
Obesity: its relation to anaesthesia. Anaesthesia 
1975;30(5):633–647.  
3. De Baerdemaeker L, Margarson M. Best anaesthetic 
drug strategy for morbidly obese patients. 
119–128. Current Opinion in Anaesthesiology 
2016;29(1):119–128 
4. Boyce JR, Ness T, Gleysteen J J. A 
Preliminary Study of the Optimal Anesthesia 
Positioning for the Morbidly Obese Patient. 
Obes Surg. 2003 Feb;13(1):4-9. doi: 
10.1381/096089203321136511.
5. Cullen A, Ferguson A. Perioperative management 
of the severely obese patient: A selective 
pathophysiological review. Canadian Journal of 
Anesthesia 2012;59(10):974–996.  
6. Leonard KL, Davies SW, Waibel BH. Perioperative 
management of obese patients. Surgical clinics of 
North America 2015;95(2):379–390.  
